Esperion Therapeutics, Inc. (ESPR)
USD 0.86
(-9.27%)
USD 0.86
(-9.27%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -2.03 USD | 53.12% |
| 2022 | -4.33 USD | 60.74% |
| 2021 | -11.03 USD | -82.31% |
| 2020 | -6.05 USD | -50.5% |
| 2019 | -4.02 USD | 46.68% |
| 2018 | -7.54 USD | -8.02% |
| 2017 | -6.98 USD | -109.61% |
| 2016 | -3.33 USD | -47.35% |
| 2015 | -2.26 USD | -1.8% |
| 2014 | -2.22 USD | 32.93% |
| 2013 | -1.71 USD | 79.63% |
| 2012 | -1.22 USD | -8.55% |
| 2011 | -1.13 USD | 0.0% |
| 2002 | -6.86 USD | -7.52% |
| 2001 | -6.38 USD | 31.76% |
| 2000 | -9.35 USD | -17.76% |
| 1999 | -7.94 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.33 USD | -191.67% |
| 2024 Q1 | 0.36 USD | 172.0% |
| 2023 FY | - USD | 53.12% |
| 2023 Q1 | -1.14 USD | -22.58% |
| 2023 Q4 | -0.50 USD | -35.14% |
| 2023 Q2 | -0.46 USD | 59.65% |
| 2023 Q3 | -0.37 USD | 19.57% |
| 2022 FY | - USD | 60.74% |
| 2022 Q4 | -0.93 USD | 7.92% |
| 2022 Q3 | -1.01 USD | 20.47% |
| 2022 Q2 | -1.27 USD | -9.48% |
| 2022 Q1 | -1.16 USD | 34.46% |
| 2021 Q4 | -1.77 USD | 32.44% |
| 2021 Q3 | -2.62 USD | -56.89% |
| 2021 Q2 | -1.67 USD | 52.29% |
| 2021 Q1 | -3.50 USD | 10.03% |
| 2021 FY | - USD | -82.31% |
| 2020 Q1 | -2.84 USD | -25.66% |
| 2020 FY | - USD | -50.5% |
| 2020 Q3 | -3.07 USD | -168.22% |
| 2020 Q4 | -3.89 USD | -26.71% |
| 2020 Q2 | 4.50 USD | 258.45% |
| 2019 Q4 | -2.26 USD | 10.32% |
| 2019 Q1 | 3.26 USD | 245.54% |
| 2019 Q2 | -2.01 USD | -161.66% |
| 2019 Q3 | -2.52 USD | -25.37% |
| 2019 FY | - USD | 46.68% |
| 2018 Q2 | -1.71 USD | 1.16% |
| 2018 FY | - USD | -8.02% |
| 2018 Q1 | -1.73 USD | -20.14% |
| 2018 Q4 | -2.24 USD | -20.43% |
| 2018 Q3 | -1.86 USD | -8.77% |
| 2017 Q1 | -1.80 USD | -40.63% |
| 2017 FY | - USD | -109.61% |
| 2017 Q4 | -1.44 USD | 22.58% |
| 2017 Q3 | -1.86 USD | 3.12% |
| 2017 Q2 | -1.92 USD | -6.67% |
| 2016 Q2 | -0.62 USD | 4.62% |
| 2016 FY | - USD | -47.35% |
| 2016 Q4 | -1.28 USD | -66.23% |
| 2016 Q3 | -0.77 USD | -24.19% |
| 2016 Q1 | -0.65 USD | -12.07% |
| 2015 Q3 | -0.57 USD | -3.64% |
| 2015 FY | - USD | -1.8% |
| 2015 Q2 | -0.55 USD | 1.79% |
| 2015 Q4 | -0.58 USD | -1.75% |
| 2015 Q1 | -0.56 USD | -14.29% |
| 2014 Q4 | -0.49 USD | 23.44% |
| 2014 Q1 | -0.51 USD | 19.05% |
| 2014 Q3 | -0.64 USD | -6.67% |
| 2014 FY | - USD | 32.93% |
| 2014 Q2 | -0.60 USD | -17.65% |
| 2013 FY | - USD | 79.63% |
| 2013 Q1 | -0.29 USD | 92.45% |
| 2013 Q2 | -0.47 USD | -62.07% |
| 2013 Q3 | -0.34 USD | 27.66% |
| 2013 Q4 | -0.63 USD | -85.29% |
| 2012 Q2 | -4.38 USD | -29.2% |
| 2012 Q4 | -3.84 USD | 17.24% |
| 2012 Q3 | -4.64 USD | -5.94% |
| 2012 Q1 | -3.39 USD | 0.0% |
| 2012 FY | - USD | -8.55% |
| 2011 FY | - USD | 0.0% |
| 2003 Q3 | -1.42 USD | 29.0% |
| 2003 Q2 | -2.00 USD | -13.64% |
| 2003 Q1 | -1.76 USD | -11.39% |
| 2002 Q2 | -1.87 USD | -6.86% |
| 2002 FY | - USD | -7.52% |
| 2002 Q3 | -1.67 USD | 10.7% |
| 2002 Q4 | -1.58 USD | 5.39% |
| 2002 Q1 | -1.75 USD | -11.46% |
| 2001 Q2 | -1.70 USD | -5.59% |
| 2001 FY | - USD | 31.76% |
| 2001 Q4 | -1.57 USD | -0.64% |
| 2001 Q3 | -1.56 USD | 8.24% |
| 2001 Q1 | -1.61 USD | 39.25% |
| 2000 Q2 | -20.60 USD | -956.41% |
| 2000 Q1 | -1.95 USD | 0.0% |
| 2000 Q3 | -5.14 USD | 75.05% |
| 2000 Q4 | -2.65 USD | 48.44% |
| 2000 FY | - USD | -17.76% |
| 1999 FY | - USD | 0.0% |